Tengion is a leader in the field of regenerative medicine. We are using a patient's own cells to develop products that regenerate, repair or replace diseased and dysfunctional human organs and tissues.

Learn about our company

Video: Tengion Neo-Urinary Conduit™

Watch as the Neo-Urinary Conduit development process is described for use in patients with bladder cancer.

Full version (4 minutes)

* IE users only: You may be redirected to upgrade
security components and install an Active X control.
The video you are linking to depicts experimental technology invented by, and procedures performed at, Children's Hospital Boston. This technology serves as the foundation for Tengion's lead product candidate, the Neo-Bladder Augment, which is currently in Phase 2 clinical trials. Tengion's Neo-Bladder Augment is investigational and has not been approved by the FDA for commercial sale. Additionally, the Neo-Bladder Augment may not be appropriate for all patients and medical results depicted in this video may not be experienced by others using this technology.